Ascendis Pharma ADR (ASND)
166.58 +1.70 (+1.03%) 04/29/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 166.00 -0.58 (-0.35%) 16:22 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ASND | EXEL | QGEN | ||
| Company | Ascendis Pharma ADR | Exelixis Inc | Qiagen N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 165.10 | 38.34 | 42.50 | ||
| High | 168.96 | 38.76 | 43.04 | ||
| Low | 165.00 | 37.67 | 42.40 | ||
| Last | 166.58 | 38.55 | 42.63 | ||
| Change | +1.70 | +0.11 | +0.16 | ||
| % Change | +1.03% | +0.29% | +0.38% | ||
| Volume | 276,900 | 1,786,200 | 936,700 | ||
| 20-Day Average Volume | 577,150 | 2,393,710 | 1,632,885 | ||
| Previous Close | 164.88 | 38.44 | 42.47 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 153.66 | 36.19 | 41.10 | ||
| 20-Day Raw Stochastic | 94.70% | 96.71% | 78.27% | ||
| 20-Day Relative Strength | 59.93% | 59.99% | 55.83% | ||
| Weighted Alpha | +23.41 | +70.36 | -4.29 | ||
| Today's Opinion | 88% Buy | 88% Buy | 40% Sell | ||
| Previous Opinion | 88% Buy | 80% Buy | 40% Sell | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.68% since 04/22/25 | +5.67% since 04/22/25 | +0.68% since 04/22/25 | ||
| Low | 155.54 on 04/24/25 | 36.56 on 04/23/25 | 41.82 on 04/25/25 | ||
| High | 168.96 on 04/29/25 | 38.76 on 04/29/25 | 43.13 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | +7.69% since 03/28/25 | +5.04% since 03/28/25 | +6.98% since 03/28/25 | ||
| Low | 124.06 on 04/09/25 | 32.38 on 04/09/25 | 38.13 on 04/04/25 | ||
| High | 168.96 on 04/29/25 | 38.76 on 04/29/25 | 43.88 on 04/15/25 | ||
| 3-Month | |||||
| %Chg | +30.60% since 01/29/25 | +16.96% since 01/29/25 | -2.60% since 01/29/25 | ||
| Low | 118.03 on 02/12/25 | 32.38 on 04/09/25 | 37.63 on 03/04/25 | ||
| High | 169.37 on 03/17/25 | 40.02 on 03/10/25 | 45.05 on 01/31/25 | ||
| 6-Month | |||||
| %Chg | +31.40% since 10/29/24 | +34.18% since 10/29/24 | -0.92% since 10/29/24 | ||
| Low | 118.03 on 02/12/25 | 31.18 on 10/30/24 | 37.63 on 03/04/25 | ||
| High | 169.37 on 03/17/25 | 40.02 on 03/10/25 | 49.30 on 01/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,052,899 | 10,593,449 | 9,440,699 | ||
| Shares Outstanding, K | 60,971 | 275,584 | 222,291 | ||
| Annual Sales | 393,500,000 | 2,168,700,000 | 1,978,210,000 | ||
| Annual Net Income | -409,120,000 | 521,270,000 | 83,590,000 | ||
| Last Quarter Sales | 187,020,000 | 566,750,000 | 521,200,000 | ||
| Last Quarter Net Income | -39,990,000 | 139,860,000 | 88,320,000 | ||
| 60-Month Beta | 0.54 | 0.57 | 0.62 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.68 on 02/12/25 | 0.55 on 02/11/25 | 0.61 on 02/05/25 | ||
| Latest Earnings Date | 05/01/25 | 04/29/25 | 05/07/25 | ||
| Most Recent Dividend | N/A | N/A | 0.027 on 12/27/02 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.39 | 18.82 | ||